Literature DB >> 10336037

Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells.

J Kim1, G N Foulks.   

Abstract

PURPOSE: To examine the effects of lissamine green and rose bengal on proliferating human corneal epithelial (HCE) cells in vitro.
METHODS: HCE cells derived from explants of discarded corneoscleral rims were cultured by the standard technique. Experimental cells were exposed to 1, 0.5, or 0.1% of either lissamine green or rose bengal for 10 min while control cells were exposed to a phosphate buffer solution (PBS). RESULT: Cell viability was 92% greater for 1% lissamine green (p = 0.013) and 81.2% greater for 0.5% lissamine green (p = 0.006) compared to 1 and 0.5% rose bengal, respectively. The difference between the effect of 0.1% rose bengal and 0.1% lissamine green on cell viability was not statistically significant (p = 0.83). Rose bengal staining of HCE cells was immediate and readily detectable with unaided eyes at all three concentrations, whereas no observable staining of healthy HCE cells was noted with lissamine green.
CONCLUSION: Rose bengal adversely affects HCE cell viability and stains normal proliferating HCE cells in contrast to lissamine green, which exhibited neither of these characteristics. Therefore, we recommend the use of lissamine green over rose bengal in evaluating ocular surface disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336037     DOI: 10.1097/00003226-199905000-00015

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye.

Authors:  Pablo Argüeso; Ann Tisdale; Sandra Spurr-Michaud; Mika Sumiyoshi; Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

2.  The challenge of dry eye diagnosis.

Authors:  Giacomo Savini; Pinita Prabhawasat; Takashi Kojima; Martin Grueterich; Edgar Espana; Eiki Goto
Journal:  Clin Ophthalmol       Date:  2008-03

Review 3.  Diagnosis of dry eye disease and emerging technologies.

Authors:  Maya Salomon-Ben Zeev; Darby Douglas Miller; Robert Latkany
Journal:  Clin Ophthalmol       Date:  2014-03-20

4.  Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease Classification.

Authors:  Astrid Rasmussen; Donald U Stone; C Erick Kaufman; Kimberly S Hefner; Nicole R Fram; Rhea L Siatkowski; Andrew J W Huang; James Chodosh; Pablo T Rasmussen; Dustin A Fife; Nathan Pezant; Kiely Grundahl; Lida Radfar; David M Lewis; Michael H Weisman; Swamy Venuturupalli; Daniel J Wallace; Nelson L Rhodus; Michael T Brennan; Courtney G Montgomery; Christopher J Lessard; R Hal Scofield; Kathy L Sivils
Journal:  ACR Open Rheumatol       Date:  2019-06-07

5.  MUC16 expression in Sjogren's syndrome, KCS, and control subjects.

Authors:  Barbara Caffery; Elizabeth Joyce; Miriam L Heynen; Lyndon Jones; Robert Ritter; Daniel A Gamache; Michelle Senchyna
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367

6.  Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis.

Authors:  Dorothea Groß; Marc Childs; Jean-Marie Piaton
Journal:  Clin Ophthalmol       Date:  2017-04-06

7.  Cost-effective treatment of ocular surface squamous neoplasia for an undocumented and uninsured New York City patient: a case report.

Authors:  Norman A Saffra; Trisha S Emborgo; Codrin E Iacob; David S Kirsch
Journal:  J Med Case Rep       Date:  2020-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.